Basic Information
NUTRINEAL PD4 WITH 1.1% AMINO ACID SOLUTION
SOLUTION, STERILE
Regulatory Information
SIN09353P
May 27, 1997
General Sale List
Therapeutic
INTRAPERITONEAL
August 10, 2023
May 30, 2025
XB05DA
Company Information
BAXTER HEALTHCARE (ASIA) PTE LTD
BAXTER HEALTHCARE (ASIA) PTE LTD
Active Ingredients
Strength: 0.85 g/l
Strength: 1.393 g/l
Strength: 0.184 g/l
Strength: 0.051 g/l
Strength: 0.51 g/l
Strength: 0.51 g/l
Strength: 0.27 g/l
Strength: 4.48 g/l
Strength: 0.955 g/l
Strength: 5.38 g/l
Strength: 0.57 g/l
Strength: 0.85 g/l
Strength: 0.3 g/l
Strength: 0.595 g/l
Strength: 0.646 g/l
Strength: 0.714 g/l
Strength: 1.071 g/l
Strength: 1.02 g/l
Strength: 0.951 g/l
Detailed Information
Contraindications
3\. **Contraindication** NUTRINEAL is contraindicated in patients with: - known hypersensitivity to any amino acids in the product or to any of the excipients - Serum urea level above 38mmol/L - uremic symptoms - metabolic acidosis - inborn errors of amino acid metabolism - liver insufficiency - severe hypokalemia - uncorrectable mechanical defects that prevent effective PD or increase the risk of infection - documented loss of peritoneal function or extensive adhesions that compromise peritoneal function
Indication Information
1\. **Therapeutic Indications** Nutritional supplement for malnourished renal failure patients (albumin concentration lower than 35g/litre) being maintained on peritoneal dialysis.